|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.35 EUR | -.--% |
|
-.--% | +1.14% |
| 06-02 | Prim, S.A. agreed to acquire Impulseo. | CI |
| 05-21 | Prim targets doubling sales, 2.5x Ebitda in 2026-2031 strategic plan | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Supplies
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 261M | - | ||||
| 14.88B | |||||
| 4.84B | - | - | |||
| 3.55B | - | - | |||
| 2.64B | - | - | |||
| 2.13B | - | - |
- Stock Market
- Stocks
- PRM Stock
- Charts Prim, S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
